Literature DB >> 1662814

Transactivation of heterologous promoters by HIV-1 tat.

P Han1, R Brown, J Barsoum.   

Abstract

To determine whether HIV-1 tat can transactivate a heterologous promoter lacking HIV sequences other than the TAR element, TAR was placed downstream of the chicken beta-actin promoter. Tat increased expression directed by the actin-TAR promoter to a degree equal to tat induction of the HIV-1 LTR. Optimal transactivation was observed when TAR was positioned downstream of the actin promoter such that the expected cap site of transcripts from this promoter would be the same as in transcripts directed by the HIV-1 LTR. Tat was able to transactivate, though to a lesser extent, a promoter consisting solely of a TATA element fused to TAR. Thus, tat induction does not require HIV-1 LTR promoter sequences other than TAR. Tat, when fused to the DNA binding domain of BPV-1 E2, was able to transactivate a truncated SV40 promoter containing upstream E2 binding sites, indicating that tat may be capable of transactivation when directed by a DNA binding protein to an upstream site in a heterologous promoter lacking all HIV sequences. Substitution of Ala for Lys at position 41 of tat in the tat-E2 fusion, a mutation which dramatically decreases tat transactivation of the HIV-1 LTR, eliminated this transactivation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1662814      PMCID: PMC332588          DOI: 10.1093/nar/19.25.7225

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  57 in total

1.  Does the human immunodeficiency virus Tat trans-activator contain a discrete activation domain?

Authors:  L S Tiley; P H Brown; B R Cullen
Journal:  Virology       Date:  1990-10       Impact factor: 3.616

2.  HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation.

Authors:  M F Laspia; A P Rice; M B Mathews
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

3.  The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain.

Authors:  J Rappaport; S J Lee; K Khalili; F Wong-Staal
Journal:  New Biol       Date:  1989-10

4.  Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein.

Authors:  M A Muesing; D H Smith; D J Capon
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

5.  Tat protein from human immunodeficiency virus forms a metal-linked dimer.

Authors:  A D Frankel; D S Bredt; C O Pabo
Journal:  Science       Date:  1988-04-01       Impact factor: 47.728

6.  HIV-1 Tat protein trans-activates transcription in vitro.

Authors:  R A Marciniak; B J Calnan; A D Frankel; P A Sharp
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

7.  The nucleotide sequence of the chick cytoplasmic beta-actin gene.

Authors:  T A Kost; N Theodorakis; S H Hughes
Journal:  Nucleic Acids Res       Date:  1983-12-10       Impact factor: 16.971

8.  Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: a novel translational control mechanism.

Authors:  I Edery; R Petryshyn; N Sonenberg
Journal:  Cell       Date:  1989-01-27       Impact factor: 41.582

9.  Structural and functional characterization of human immunodeficiency virus tat protein.

Authors:  S Ruben; A Perkins; R Purcell; K Joung; R Sia; R Burghoff; W A Haseltine; C A Rosen
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

10.  Human immunodeficiency virus type 1 Tat does not transactivate mature trans-acting responsive region RNA species in the nucleus or cytoplasm of primate cells.

Authors:  D J Chin; M J Selby; B M Peterlin
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

View more
  6 in total

1.  Inhibition of human immunodeficiency virus type 1 and type 2 Tat function by transdominant Tat protein localized to both the nucleus and cytoplasm.

Authors:  M J Orsini; C M Debouck
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

2.  Inhibition of HIV-1 by a Lentiviral Vector with a Novel Tat-Inducible Expression System and a Specific Tropism to the Target Cells.

Authors:  Touraj Farazmandfar; Mohammad Reza Haghshenas; Majid Shahbazi
Journal:  Hum Gene Ther       Date:  2015-08-06       Impact factor: 5.695

3.  Oligoclonal T cells are infiltrating the brains of children with AIDS: sequence analysis reveals high proportions of identical beta-chain T-cell receptor transcripts.

Authors:  W L Lin; J E Fincke; L R Sharer; D S Monos; S Lu; J Gaughan; C D Platsoucas; E L Oleszak
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

4.  A recombinant adenoviral vector with a specific tropism to CD4-positive cells: a new tool for HIV-1 inhibition.

Authors:  Abtin Behmardi; Touraj Farazmandfar
Journal:  Drug Deliv Transl Res       Date:  2022-01-31       Impact factor: 5.671

5.  A novel growth-inducible gene that encodes a protein with a conserved cold-shock domain.

Authors:  K Ito; K Tsutsumi; T Kuzumaki; P F Gomez; K Otsu; K Ishikawa
Journal:  Nucleic Acids Res       Date:  1994-06-11       Impact factor: 16.971

6.  Autoreactive cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected subjects.

Authors:  F di Marzo Veronese; D Arnott; V Barnaba; D J Loftus; K Sakaguchi; C B Thompson; S Salemi; C Mastroianni; A Sette; J Shabanowitz; D F Hunt; E Appella
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.